Clinical trials and research at SABCS 2026

Dec 8–11, 2026 San Antonio, TX ~11k attendees Website

58 organizations at SABCS 2026 present work in clinical trials and research, led by universities and research institutes. Between them they bring 186 presentations to the program. Most represented: University of Chicago, City of Hope and Medical University of South Carolina. As of Nov 10, 2026.

All 956 organizations at SABCS 2026 →

Format
Top represented
Showing 1–3 of 58 organizations
OrganizationSABCS 2026 Attendance
Academic
Private research university in Chicago with an academic medical center and cancer research programs.
Poster
Wed Dec 9
12:30–2pm
Patterns of taxane-induced peripheral neuropathy among patients with breast cancer
Exhibit Hall
Adverse Effects of Cancer Treatment and Symptom Management
Poster
Wed Dec 9
12:30–2pm
Evaluating Oncotype DX as a Mediator Between Digital Pathology Deep Learning Models and Breast Cancer Recurrence
Exhibit Hall
Clinical Biomarkers, Translational Research, and Precision Medicine
Poster
Wed Dec 9
12:30–2pm
Cytoplasmic Trop-2 Predicts Sacituzumab Govitecan Uptake and Clinical Benefit in Metastatic Breast Cancer
Exhibit Hall
Clinical Biomarkers, Translational Research, and Precision Medicine
Poster
Wed Dec 9
5–6:30pm
Talk
Thu Dec 10
7:39–7:42am
Histology-specific performance of genomic and digital pathology risk models in TAILORx
Hemisfair 3
Artificial Intelligence, Computational Biology, and Systems Biology
Talk
Thu Dec 10
8:12–8:15am
Poster
Thu Dec 10
12:30–2pm
Poster
Thu Dec 10
12:30–2pm
Potential use of GLP-1 receptor agonists in combination with endocrine therapy for treating women with ER+ breast cancer
Exhibit Hall
Breast Cancer: Early Stage - Hormone Receptor Positive
Poster
Thu Dec 10
12:30–2pm
Predicting neoadjuvant therapy response from breast cancer core biopsies using multi-modal AI
Exhibit Hall
Artificial Intelligence, Computational Biology, and Systems Biology
Poster
Thu Dec 10
5–6:30pm
Hypoxic neutrophils predict immunotherapy benefit in high-risk, early-stage triple-negative breast cancer
Exhibit Hall
Breast Cancer: Early Stage - Triple Negative
Poster
Thu Dec 10
5–6:30pm
Poster
Thu Dec 10
5–6:30pm
Session
Fri Dec 11
7–8:30am
Poster
Fri Dec 11
12:30–2pm
Poster
Fri Dec 11
12:30–2pm
Feasibility of Genome-wide Mapping of 5-methylcytosines to Evaluate Epigenetic Biomarkers in Breast Cancer
Exhibit Hall
Clinical Biomarkers, Translational Research, and Precision Medicine
City of Hope
Duarte, CA
Hospitals
NCI-designated comprehensive cancer center and research organization with a national network of cancer treatment sites.
Booth
Exhibiting at Booth 945
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Poster
Wed Dec 9
5–6:30pm
64Cu-dota-trastuzumab-pet
Exhibit Hall
Imaging / Early Detection
Poster
Wed Dec 9
5–6:30pm
First-line Real-world Outcomes in PIK3CA-mutant HR+, HER2- Advanced Breast Cancer in the US
Exhibit Hall
Real-World Data and Real-World Evidence
Session
Thu Dec 10
7–8:30am
Poster Spotlight 13: Triple Negative Breast Cancer
Hemisfair 1-2
Session
Thu Dec 10
1–2pm
Rapid Fire 8
Stars at Night 1-2
Poster
Thu Dec 10
5–6:30pm
Poster
Thu Dec 10
5–6:30pm
Poster
Fri Dec 11
12:30–2pm
Beyond CDK4/6 Inhibition: Abemaciclib as a Metabolic Modulator
Exhibit Hall
Clinical Biomarkers, Translational Research, and Precision Medicine
Academic
A public academic health sciences university with medical education, patient care and cancer research in Charleston.
Session
Tue Dec 8
11am–12:30pm
Poster
Wed Dec 9
12:30–2pm
Poster
Wed Dec 9
12:30–2pm
Poster
Wed Dec 9
12:30–2pm
Poster
Wed Dec 9
5–6:30pm
Poster
Thu Dec 10
12:30–2pm
Poster
Thu Dec 10
12:30–2pm
Inflammatory Breast Cancer Recognition Among Rural Primary Care Providers: Confidence, Resource Gaps, and Comparisons to Urban Practices
Exhibit Hall
Policy, Access to Care, Health Outcomes and Cancer Care Delivery
Poster
Thu Dec 10
5–6:30pm
Poster
Thu Dec 10
5–6:30pm
Targeting luminal-to-HER2E transition during endocrine resistance to suppress metastasis in HR+ breast cancer
Exhibit Hall
Breast Cancer: Metastatic - Hormone Receptor Positive

Explore the full SABCS 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Antonio. Leave your work email and we’ll be in touch.

Privacy

Download the full SABCS 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers in clinical trials and research

Tell us what you sell and we’ll find the people at organizations working on clinical trials and research most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse SABCS 2026 by

Exhibit hall

Not affiliated with the San Antonio Breast Cancer Symposium, UT Health San Antonio or the American Association for Cancer Research. Organization details are derived from SABCS’s published program and exhibitor list. Submit a correction